SHORT MINI FUTURE WARRANT - BRISTOL-MYERS SQUIBB

SHORT MINI FUTURE WARRANT - BRISTOL-MYERS SQUIBB Share Price

DE000GQ00EE2

Market Closed - BOERSE MUENCHEN 11:56:40 07/06/2024 pm IST
2.201 ^EUR	-0.14%

Current month	-0.14%
1 month	+12.87%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart BRISTOL-MYERS SQUIBB COMPANY

Chart SHORT MINI FUTURE WARRANT - BRISTOL-MYERS SQUIBB

Latest news about BRISTOL-MYERS SQUIBB COMPANY

Geron shares surge after U.S. FDA approves blood disorder drug	07/06	RE
I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers	05/06	MT
Bristol Myers Squibb Announces Opdivo Plus Yervoy Significantly Improved Overall Survival Compared to Lenvatinib or Sorafenib as First-Line Treatment for Patients with Advanced Hepatocellular Carcinoma	05/06	AQ
I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers	05/06	CI

More news

Quotes 5-day view

Date	Price	Change
07/24/07	2.201	-0.14%
06/24/06	2.204	+0.78%
05/24/05	2.187	+2.92%
04/24/04	2.125	+0.85%
03/24/03	2.107	-4.40%

Real-time BOERSE MUENCHEN

Last update June 07, 2024 at 11:56 pm IST

More quotes

Static data

Product type	Knock-Out with Stop Loss
Buy / Sell	PUT
Underlying	BRISTOL-MYERS SQUIBB COMPANY
Issuer	Goldman Sachs
WKN	GQ00EE
ISIN	DE000GQ00EE2
Date issued	25/07/2023
Strike	64.95 $
Maturity	Unlimited
Parity	10 : 1
Emission price	0.14 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	2.304 €
Lowest since issue	0.228 €

Company Profile

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.

Sector

More about the company

Ratings for Bristol-Myers Squibb Company

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: Bristol-Myers Squibb Company

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

41.48 USD

Average target price

53.19 USD

Spread / Average Target

+28.24%

Consensus